St Guoyi disclosed the Research Report on March 14. The company received Tianfeng Securities Co.Ltd(601162) , e fund and other institutions through a teleconference on March 13. Ding Zhen, vice president and Secretary of the company, and Wang Yaxing, chief financial officer, participated in the teleconference.
With regard to the impact of the transfer of the equity of Shangluo Xi’An International Medical Investment Company Limited(000516) Central Hospital, the company said that the company had signed the framework agreement on equity transfer of Shangluo Xi’An International Medical Investment Company Limited(000516) Central Hospital Co., Ltd. with Shangluo transportation investment and Construction Co., Ltd. on March 7, and planned to transfer 99% of the equity of Shangluo Xi’An International Medical Investment Company Limited(000516) Central Hospital (hereinafter referred to as “Shangluo hospital”), Shangluo Trading Investment Co., Ltd. plans to transfer the above equity held by the company with monetary funds. The equity transfer of Shangluo hospital is based on the company’s development strategy and investment plan, focusing on “focusing on the main business and highlighting the advantages”. The purpose of this transfer is to gather the future development momentum of the company, fully grasp the location advantages of national central cities, layout the construction and operation of Xi’an Xi’An International Medical Investment Company Limited(000516) Central Hospital, Xi’an high tech hospital and Xi’an International Rehabilitation Medical Center Hospital, and realize the optimal allocation of resources.
The company believes that on the whole, the equity transfer of Shangluo hospital is positive and beneficial to the development of the company, which is reflected in three aspects: first, stripping the liabilities and losses of Shangluo hospital will further optimize the assets of listed companies; Second, in view of the small resident population, limited scale of medical service market and the current situation of operation and investment return in Shangluo area, the transfer of Shangluo hospital is conducive to the company’s light loading, concentration of advantages and steady improvement of the operation of two large hospitals located in Xi’an (Medical Center in Central and Western China); Third, the rehabilitation hospital with 3600 beds will be put into use in the future, which will enable the company to complete the layout of three large hospitals in Xi’an. The equity transfer of Shangluo hospital is conducive to the revenue and profit growth of listed companies.
At present, the company’s Xi’an high tech hospital and Xi’an Xi’An International Medical Investment Company Limited(000516) central hospital are in the rectification period. The company expects that the two hospitals will recover faster after the follow-up visit: first, the two hospitals are mature hospitals. The high-tech hospital has been in operation for 20 years and the Xi’An International Medical Investment Company Limited(000516) central hospital has been in operation for more than two years. It has influence in the industry and is a medical service guarantee institution for local people to seek medical treatment; Second, the operation of the two hospitals increased significantly in 2021; Third, according to historical experience, affected by the epidemic and other aspects in 2020, both hospitals achieved rapid business growth after returning to work.
